For The Better

Which fallen growth stock is a potential multibagger?

These top stocks have tremendous potential left for investors to capitalize on.

The EV maker’s management talks R2 platform launch and its expectation of a “significant discrepancy” between Q4 vehicle production and delivery numbers.

Recession or not, security software is a must-have for enterprise customers.

2023 could be a turbulent year for the company.

One analyst thinks e-commerce growth is starting to accelerate.

Thinking about investing in Disney stock? Make sure you’re aware of these three things.

Investors may have overlooked Carnival stock’s more significant competitors.

This embattled casino company has outperformed in 2022. But its long-term future is uncertain.

Consistently investing your cash in both up and down markets can make you richer in the long run.

Is the plant-based meat company capable of generating real returns?

This company is losing a lot of money, putting its juicy 16% yield at risk.

Meta Platforms is going back to what it does best.

AstraZeneca’s new asthma rescue treatment could soon be approved in the United States for adults.

The chip giant’s cash flow problems led it to seek a funding partner.

Whether you buy it or not, you need to know about this innovative cryptocurrency. It’s like a clearance sale on the future of money.

Now is a great time to buy shares of this high-quality cash cow, down more than 12% over the past month.

Check out this table to understand how your Social Security rises or falls depending on when you claim it.

There are a few reasons to consider opening a position with the fintech giant.